- Home
- MCRB vs INBK Comparison
MCRB vs INBK Comparison
Compare MCRB & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- INBK
- Stock Information
- Founded
- MCRB 2010
- INBK 1999
- Country
- MCRB United States
- INBK United States
- Employees
- MCRB N/A
- INBK N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- INBK Major Banks
- Sector
- MCRB Health Care
- INBK Finance
- Exchange
- MCRB Nasdaq
- INBK Nasdaq
- Market Cap
- MCRB 165.3M
- INBK 191.0M
- IPO Year
- MCRB 2015
- INBK N/A
- Fundamental
- Price
- MCRB $17.23
- INBK $24.47
- Analyst Decision
- MCRB Hold
- INBK Hold
- Analyst Count
- MCRB 4
- INBK 3
- Target Price
- MCRB $73.67
- INBK $30.67
- AVG Volume (30 Days)
- MCRB 245.5K
- INBK 33.7K
- Earning Date
- MCRB 11-12-2025
- INBK 10-22-2025
- Dividend Yield
- MCRB N/A
- INBK 1.01%
- EPS Growth
- MCRB N/A
- INBK N/A
- EPS
- MCRB 10.22
- INBK 1.76
- Revenue
- MCRB N/A
- INBK $106,219,000.00
- Revenue This Year
- MCRB N/A
- INBK $6.07
- Revenue Next Year
- MCRB N/A
- INBK $26.33
- P/E Ratio
- MCRB $1.68
- INBK $13.55
- Revenue Growth
- MCRB N/A
- INBK 4.74
- 52 Week Low
- MCRB $6.53
- INBK $19.54
- 52 Week High
- MCRB $24.67
- INBK $43.27
- Technical
- Relative Strength Index (RSI)
- MCRB 52.55
- INBK 51.96
- Support Level
- MCRB $17.00
- INBK $23.52
- Resistance Level
- MCRB $24.67
- INBK $24.67
- Average True Range (ATR)
- MCRB 1.79
- INBK 0.73
- MACD
- MCRB -1.40
- INBK -0.04
- Stochastic Oscillator
- MCRB 69.86
- INBK 44.92
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.